Transjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free device

BACKGROUND: Administering growth-hormone therapy (GHT) is a long-term treatment, associated with avoidance and phobic behaviors in the children involved. The current study examined GHT users’ perceptions of a new needle-free device (ZomaJet Vision X [10 mg/mL]) with a lower injection volume compared...

Descripción completa

Detalles Bibliográficos
Autor principal: Kaptein, Ad A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728268/
https://www.ncbi.nlm.nih.gov/pubmed/23926423
http://dx.doi.org/10.2147/PPA.S46990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728268/
https://www.ncbi.nlm.nih.gov/pubmed/23926423
http://dx.doi.org/10.2147/PPA.S46990

Ejemplares similares